Factors to consider when selecting a nebulizer for a new inhaled drug product development program.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 25758911)

Published in Expert Opin Drug Deliv on March 10, 2015

Authors

Mark Elphick1, Dirk von Hollen, John N Pritchard, Kurt Nikander, Lucy E A Hardaker, Ross H M Hatley

Author Affiliations

1: Respironics, Inc., a Philips Healthcare Co. , 200 Franklin Square Drive, Somerset, 08873 NJ , USA.

Articles by these authors

Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalers. J Allergy Clin Immunol (2003) 2.43

Thirteen-year follow-up of early intervention with an inhaled corticosteroid in patients with asthma. J Allergy Clin Immunol (2009) 1.43

In vitro characterization of the OptiChamber Diamond valved holding chamber. J Aerosol Med Pulm Drug Deliv (2014) 1.39

Delivery of iloprost inhalation solution with the HaloLite, Prodose, and I-neb Adaptive Aerosol Delivery systems: an in vitro study. Respir Care (2007) 1.12

In vitro characterization of the I-neb Adaptive Aerosol Delivery (AAD) system. J Aerosol Med Pulm Drug Deliv (2010) 0.90

Domiciliary experience of the Target Inhalation Mode (TIM) breathing maneuver in patients with cystic fibrosis. J Aerosol Med Pulm Drug Deliv (2010) 0.89

Systemic availability and lung deposition of budesonide via three different nebulizers in adults. Ann Allergy Asthma Immunol (2003) 0.88

Evaluation of patient-reported outcomes and quality of life with the I-neb AAD system in patients with chronic obstructive pulmonary disease. J Aerosol Med Pulm Drug Deliv (2010) 0.85

Ophthalmologic findings in children with asthma receiving inhaled budesonide. J Allergy Clin Immunol (2008) 0.84

Methodology for the in vitro evaluation of the delivery efficiency from valved holding chambers with facemasks. J Aerosol Med Pulm Drug Deliv (2013) 0.84

Variation in pediatric aerosol delivery: importance of facemask. J Aerosol Med (2005) 0.84

Bone mineral density in children treated with daily or periodical inhaled budesonide: the Helsinki Early Intervention Childhood Asthma study. Pediatr Res (2010) 0.83

An instrumented valved holding chamber with facemask to measure application forces and flow in young asthmatic children. J Aerosol Med Pulm Drug Deliv (2014) 0.80

Challenges and opportunities in respiratory drug delivery devices. Expert Opin Drug Deliv (2010) 0.80

Continuous versus intermittent inhaled corticosteroid (budesonide) for mild persistent asthma in children--not too much, not too little. Thorax (2011) 0.80

Lung deposition of 99mTc-radiolabeled albuterol delivered through a pressurized metered dose inhaler and spacer with facemask or mouthpiece in children with asthma. J Aerosol Med Pulm Drug Deliv (2014) 0.76

Skin thickness in children treated with daily or periodical inhaled budesonide for mild persistent asthma. The Helsinki early intervention childhood asthma study. Pediatr Res (2010) 0.76

Response. J Aerosol Med Pulm Drug Deliv (2014) 0.75

In vitro comparison of the effect of inhalation delay and flow rate on the emitted dose from three valved holding chambers. J Aerosol Med Pulm Drug Deliv (2014) 0.75

Airway identification within planar gamma camera images using computer models of lung morphology. Pharm Res (2005) 0.75